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The aim of the study was to develop a rapid, cost-effective combined testing method to assess the in-
direct effect of compounds interfering with sex steroid synthesis and to determine complex effects of
atrazine on estrogen and androgen synthesis in vitro on H295R human cell line. Steroidogenic assay was
performed on H295R human adrenocortical carcinoma cell line. Instead of standard analytical methods,
bioluminescence bioreporter assays (Saccharomyces cerevisiae BLYES and BLYAS) were used to measure
estrogenic and androgenic effects of sex steroid hormones released by human cells in response to
atrazine. Atrazine resulted in elevated estrogen production presumably due to its well documented
inductive effect on aromatase on H295R cell line, detected by BLYES. Interestingly, results of BLYAS test
showed concentration-dependent increase of androgen production in H295R cells. That indicates that
atrazine can not only increase estrogen level via aromatase induction, but may interfere in androgen
synthesis as well. The combined method allows us to assess the androgenic and estrogenic effect of sex
steroids produced by human cells in increased or decreased quantity as a result of the different chem-
icals, without determining speciﬁc analytical measurement endpoints, by using the yeast based biolu-
minescent bioreporter test.
© 2016 Elsevier Ltd. All rights reserved.. Szoboszlay).1. Introduction
Endocrine disrupting chemicals (EDCs) interfere with hormone
signalling in a variety of ways depending on the chemical and the
hormonal system. Many of these chemicals interact with sex
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estrogenic effects); others affect key enzymes involved in steroid
synthesis and breakdown.
Atrazine (2-chloro-4-ethylamino-6-isopropylamino-1,3,5-
triazine) is a member of chlorinated s-triazine group of herbicides
having been widely used worldwide over the last 50 years. Euro-
pean Union has banned atrazine since 2004, but it is one of the
most extensively used herbicide in North America (and several
other countries) for pre- and post emergence control of broadleaf
and grassy weeds in corn, sorghum, sugarcane and other crops
(Sass&Colangelo, 2006; Ghosh&Philip, 2006).
Although atrazine does not bind to androgen and estrogen re-
ceptors (Kojima et al., 2003; Roberge et al., 2004;
Suzawa&Ingraham, 2008), it has been associated with various
endocrine disrupting effects including reduction of number and
motility of sperm (Kniewald et al., 2000), hermaphroditism and
demasculinization in frogs (Hayes et al., 2002, 2006, 2010, 2011),
change in sex- and estrogen-androgen ratio in ﬁsh and amphibian
(Oka et al., 2008; Suzawa&Ingraham, 2008). Furthermore, atrazine
has been reported to up-regulate aromatase activity in vitro in
H295R human adrenocortical carcinoma cells (Sanderson et al.,
2000, 2002). Aromatase enzyme is responsible for the conversion
of androgens to estrogens; therefore, atrazine causes elevated es-
trogen production due to its inductive effect on aromatase. More-
over, atrazine induces tumours of the mammary gland and
reproductive organs (Pinter et al., 1990). According to the World
Health Organization International Agency for Research on Cancer
(IARC) there is sufﬁcient evidence in experimental animals for the
carcinogenicity of atrazine, however, in humans, atrazine is not
classiﬁable (Group 3) since 1999 (IARC, 1999).
In 1996, EPA formed the Endocrine Disruptor Screening and
Testing Advisory Committee (EDSTAC), charging the Committee to
develop a screening program that would provide necessary infor-
mation to make regulatory decision about the endocrine effects of
approximately 87 000 existing and new chemicals that require
screening for endocrine disrupting activity. EDSTAC created a tiered
Conceptual Framework consisting three major activities: i. Priority
setting to obtain and evaluate existing data and to identify chemical
substances and mixtures requiring further testing; ii. Tier 1
Screening to detect chemicals and mixtures capable of interacting
with estrogen, androgen, or thyroid (EAT) hormone system; iii. Tier
2 Screening to precisely determine and identify the mode of action
of the endocrine disrupting ability of chemicals and mixtures
selected by Priority setting and/or Tier 1 (EDSTAC, 1998).
There are various techniques and methods available to analyze
endocrine disrupting effects of EDCs. However, many of these tests
focus on certain endpoints, e.g., estradiol and testosterone con-
centration measured by ELISA, or speciﬁc receptor-binding and
gene-expression assays, while the complexity of multiple biological
effects of EDCs on endocrine system is poorly investigated.
Herein we report a novel test method and a concentration-
response study for determine the complex effects of atrazine on
sex steroid synthesis in H295R human adrenocortical carcinoma
cells.
The human H295R adrenocortical carcinoma cell line expresses
most of the key enzymes required for steroidogenesis (Gazdar et al.,
1990; Rainey et al., 1993, 1994). Therefore, the cell line is a useful
in vitromodel to investigate steroidogenic pathways and processes
(Hecker & Giesy, 2008; USEPA, 2011).
Sanseverino et al. (2005) and Eldridge et al. (2007) developed a
low cost and rapid bioassay, measuring estrogenic-, androgenic
potential and toxicity with the purpose to create an assay that is
applicable for Tier 1 high-throughput screening in EDSTAC and for
monitoring endocrine-disrupting activity of unknown chemicals.
Saccharomyces cerevisiae strains (BLYES and BLYAS) wereconstructed by inserting human estrogen and androgen receptor
genes in the chromosome, a series of estrogen and androgen
response elements, and the prokaryotic lux-genes of Photorhabdus
luminescence. When an estrogenic or androgenic compound enters
the cell of Saccharomyces cerevisiae BLYES and BLYAS, it is bound by
the human estrogen and androgen receptor, a complex is formed,
activating the lux-genes, and resulting in bioluminescence. The
constitutive control strain (S. cerevisiae BLYR) is used to assess the
toxicity of samples with a decrease in bioluminescence.
These bioluminescence bioreporters are appropriate tools to
measure effects of estrogens and androgens. Here, we have com-
bined in vitro steroidogenesis assay with bioreporters to reveal
indirect and complex effects of atrazine on sex steroid synthesis.
2. Materials and methods
2.1. H295R cell line and culture conditions
H295R human adrenocortical cell line was obtained from the
CLS Cell Line Service GmbH (Germany, NCIeH295R, no. 300483).
Cells were cultured as described in OCSPP Guideline 890.1550.
Brieﬂy, upon arrival, cells were propagated in a complete growth
medium consisting of 1:1 mixture of DMEM:F12 medium supple-
mented with ITS þ Premix (insulin, transferrin, selenium, bovine
serum albumin, and linoleic acid; ﬁnal dilution 1:100; BD) and fetal
calf serum FCS (ﬁnal concentration 2.5% v/v) for at least ﬁve pas-
sages. Aliquots were regularly frozen in liquid N2. Cells were har-
vested between passages 5 and 10 by 0.5% trypsin and 2  105 cells
were plated into 24 wells' plates resulting in 60e70% conﬂuency by
24 h. H295R cells were exposed to test compounds or medium and
solvent (1 ml DMSO/ml medium) controls for 48 h. For steroido-
genesis assay, cells were treatedwith the known aromatase inducer
forskolin (CAS 66575-29-9, purity >99%), inhibitor prochloraz (CAS
67747-09-5, purity 98.6%) and atrazine. Forskolin is also an
adenylyl-cyclase activator chemical and results in an elevated cAMP
level. That is a second messenger and plays an essential role in the
adrenal steroidogenesis by activating the protein kinase A (PKA)
signalling pathway (Seamon et al., 1981; Hecker et al., 2006) and
resulting in increased estrogen and androgen level at the same
time. Prochloraz acts as an androgen and estrogen receptor
antagonist and inhibit steroidogenic enzymes such as CYP17A1
(Vinggaard et al., 2006) and CYP19A1 (aromatase) (Andersen et al.,
2002) decreasing the level of testosterone and estrogens. Chemicals
were purchased from Sigma-Aldrich Ltd. Cells in 24-well culture
plates containing 1 ml medium per well, were exposed to various
concentrations of atrazine (1, 3, 10, 30, 100 and 300 mM), forskolin
(0.03, 0.1, 0.3, 1, 3 and 10 mM) and prochloraz (0.01, 0.03, 0.1, 0.3, 1
and 3 mM) dissolved in 1 ml of dimethyl-sulfoxide (DMSO; CAS67-
68-5, purity 99.7%, Sigma-Aldrich). In parallel with atrazine,
treatments with at least two different concentrations of positive
control chemicals (forskolin and prochloraz) were run as quality
controls at the same time, according to the recommendations of the
OCSPP Guideline. At the end of the experiment, culture superna-
tants were collected and frozen at20 C. Cells were rinsed 3 times
with PBS and the plate was frozen after adding 200 ml of TRISol into
each well. All treatments were carried out in duplicate in three
independent experiments.
2.2. BLYES, BLYAS and BLYR test
S. cerevisiae strains BLYES, BLYAS and BLYR (The University of
Tennesse, Knoxville) harbouring plasmids with leucine and uracil
selective markers were stored at 80 C and were grown overnight
at 30 C and 200 rpm to an OD600 of 1.0 in a modiﬁed minimal
medium (YMM) without leucine and uracil (Routledge & Sumpter,
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Bioluminescence (detected in photon counts per second, CPS)
was measured after 5 h by a VictorX Multilabel Plate Reader (Per-
kin-Elmer Inc., USA). BLYES, BLYAS and BLYR tests have been carried
out in triplicates for each supernatant sample originated from the
steroidogenesis assay and pure compounds (atrazine, prochloraz,
forskolin) and have been repeated three times using
S. saccharomyces cells from different stocks each time. 17b-estradiol
(E2) and 5a-dihydrotestosterone (DHT) (concentration range from
2E-05 to 3.5E-02 mM) dissolved in 20 ml methanol have been used as
positive controls in each assay. Negative controls included wells
with YMM þ yeast cells and YMM þ yeast cells þ methanol.
2.2.1. Cross-reaction between BLYAS and BLYES tests
In order to assess the extent of possible cross-reaction, we
evaluated the E2 and DHT responses detected in BLYAS and BLYES
tests, respectively. 20 ml of E2 (concentration range tested from
1.8Eþ 02 mM to 3.7Eþ 05 mM) and DHT (from 5.4Eþ 01 mM to
1.1Eþ 05 mM) dissolved in methanol were placed into wells of
black, sterile, ﬂat bottom, 96-well microplate (Grenier Bio-one
Gmbh, Germany), then after evaporation of the solvent 200 ml
BLYES and BLYAS was added to the DHT and E2 containing wells,
respectively.
2.2.2. Estrogenicity and androgenicity of the pure test compounds
To determine the estrogenic, androgenic and cytotoxic effects of
the pure test compounds, BLYES, BLYAS and BLYR tests have been
carried out with atrazine (1, 3, 10, 30, 100 and 300 mM), forskolin
(0.03, 0.1, 0.3, 1, 3 and 10 mM) and prochloraz (0.01, 0.03, 0.1, 0.3, 1
and 3 mM) dissolved in 20 ml DMSO. Wells with YMM þ yeast cells
and YMM þ yeast cells þ DMSO were applied as negative controls.
2.2.3. Measuring estrogenicity and androgenicity of the steroid
hormones produced by H295R cells
Supernatants of H295R human cells after 48 h exposure to
various concentrations of atrazine, forskolin and prochloraz have
been examined for their estrogenic and androgenic hormone ac-
tivity. Supernatants of H295R cells treated with aromatase inducer
forskolin and inhibitor prochloraz have been used as positive
controls which chemicals also have inductive and inhibitory effects
on testosterone production. Negative controls for the basal hor-
mone production of H295R (Medium þ H295R) and solvent con-
trols (SC ¼ Medium þ H295R þ DMSO) were also included. 20 ml
samples were placed appropriate wells. Subsequently 200 ml of
cultures (BLYES, BLYAS and BLYR) were placed into each well,
respectively. Bioluminescence values of supernatants of H295R
treated with atrazine, forskolin and prochloraz have been
compared to the solvent control (SC).
2.2.4. Data analyses
Statistical analyses of bioluminescence data have been per-
formed using GraphPad Prism 5 software (GraphPad Software Inc.,
San Diego, USA). All data are expressed as means and standard
deviations. Differences among all treatments have been deter-
mined using analysis of variance (ANOVA) followed by the Tukey's
post hoc test, differences with p  0.05 were considered signiﬁcant.
For curve ﬁtting and EC50 calculations, normalized biolumines-
cence values (CPS) versus the log of chemical concentrations (mM)
were plotted using the four-parametric logistic equation (Hill-
equation or variable slope sigmoidal equation) as a non-linear
regression model to generate concentration-response curves.
Bioluminescence intensiﬁcation has been determined as calcu-
lated in Krifaton et al. (2013). Brieﬂy:
Bioluminescence intensiﬁcation (%) ¼ 1  [(SC e S)/SC]  100where SC is the arithmetic mean of the bioluminescence values of
parallel solvent controls after the incubation time and S represents
the bioluminescence average value of parallel samples, determined
at the time of contact.
3. Results
To examine endocrine disrupting effects of atrazine on steroid
synthesis in H295R cells, a combined method with BLYES, BLYAS
and BLYR bioreporters was developed. The literary EC50 values are
6.3 ± 2.4E-04 mM for E2 and 1.1 ± 0.5E-02 mM for DHT as positive
control chemicals, using BLYES and BLYAS test, respectively
(Sanseverino et al., 2009). The EC50 values (means with standard
deviations from the independent bioreporter assays) were
6.46 ± 3.7E-04 mM for E2 and 3.91 ± 2.0E-03 mM for DHT measured
in our study, thus the sensitivity of the bioreporter tests was
sufﬁcient.
3.1. Cross-reactivity between BLYES and BLYAS tests
Cross-reactivity was detected between the BLYES and BLYAS
tests; the androgenic activity of E2 measured in the BLYAS test is
nearly 30 times weaker than the effect of DHT; the total estrogenic
activity of DHT when assessed in the BLYES test is almost 600 times
weaker than the effect of E2. The estrogenic and androgenic effects
of the estrogens and androgens produced by human cells in
response to atrazine were approximately 60 000 times and 7000
times weaker, respectively than that of E2 and DHT (Table 1). The
atrazine concentrations in the steroidogenesis assay, due to which
the supernatant of human cells causes 50% of the maximum es-
trogenic and androgenic effects in the bioreporter tests (EC50), are
largely the same (Fig. 3). Therefore, it can be concluded that the
increased estrogenic and androgenic effects in supernatants after
exposure to atrazine, detected in the BLYES and BLYAS tests, are
indeed due to the increased level of both the androgen and estro-
gen hormones and not to the cross-reaction of estrogens with the
androgen receptor and the androgens with the estrogen receptor.
3.2. Estrogenicity and androgenicity of the pure test compounds
In order to evaluate whether by attaching to the human estro-
gen and androgen receptors, forskolin, prochloraz and atrazine,
directly are able to cause increase in bioluminescence, the test
chemicals were examined in BLYES, BLYAS and cytotoxicity
assessing BLYR tests (the concentration range was identical to the
one used in the steroidogenesis assay). The bioluminescence values
evoked by the different compounds and expressed in % compared
to the solvent control value are shown in Fig. 1. None of the
chemicals resulted in an increase in bioluminescence as measured
in the BLYES and BLYAS tests. They were not cytotoxic in the BLYR
test in the highest concentration applied: forskolin, prochloraz and
atrazine resulted in 4.3e12.1%, 6e12.6% and maximum 14.7%
decrease in bioluminescence, respectively, and these values were
not found signiﬁcantly different from the solvent control. However,
a signiﬁcant decrease in bioluminescence was detected in case of
pure prochloraz in BLYES and atrazine and forskolin in BLYAS tests,
respectively (Fig. 1). Forskolin does not have cytotoxic effect, up to
the best of the authors' knowledge. Although the decrease in the
bioluminescence caused by forskolin is statistically signiﬁcant, it is
small-scale, especially as BLYES and BLYAS have only a modest
bioluminescence (hence their role is to respond with elevated
luminescence in presence of chemicals that are able to bind to the
estrogen and androgen receptors), whereas the basic biolumines-
cence of BLYR strain is two orders of magnitude larger. Prochloraz is
also an imidazole-type fungicide inhibiting the ergosterol
Table 1
Cross-reactivity between BLYES and BLYAS tests and relative estrogenic and androgenic activity of the compounds compared to the corresponding assay standard.
Compound BLYES test BLYAS test
Estrogenic activitya EC50 (mM) Androgenic activitya EC50 (mM)
E2 1 2,740E  04 1/27 1,290E  01
DHT 1/571 1,570E  01 1 4,730E  03
H295R supernatant after atrazine exposure 1/61350 1,678Eþ 01 1/7256 3,438Eþ 01
a Ratio of the EC50 of the corresponding assay standard divided by the EC50 of a compound.
Fig. 1. Estrogenic, androgenic and cytotoxic effects of the pure compounds on S. cerevisiae bioluminescence bioreporter tests measured by BLYES (A), BLYAS (B) and BLYR (C) after
5 h contact time. Bioluminescence data are expressed in percentage of control (100%). One-way ANOVA followed by the Tukey's post hoc test was used. Data are presented as
mean ± SD of three independent experiments. (*) signiﬁcantly different from control (p < 0.05), (**, þþ) signiﬁcantly different from control (p < 0.01), (***, þþþ) signiﬁcantly
different from control (p < 0.001). Test compounds were tested three times with BLYES/BLYAS/BLYR tests in triplicate.
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cause a decrease in bioluminescence in the bioreporters due to its
anti-fungal activity. According to Sanseverino et al. (2009), atrazine
has a cytotoxic effect on the bioreporters in relatively high dose
(IC20: 5.3Eþ 02 mM in BLYR) corresponding with our results
(highest decrease in bioluminescence was measured at 3Eþ 02 mM
of atrazine).
Our conclusion, based on these results, is that test chemicals
alone cannot cause an increase in bioluminescence in the bio-
reporter test. Furthermore they cannot attach either to the estrogen
or the androgen receptors directly. Therefore, when examining the
supernatants of human cells originating from the steroidogenesis
assay, we excluded that the pure test chemicals cause an increase in
bioluminescence in the bioreporter tests.
3.3. Hormone effect of supernatants of H295R cells after exposure
to test compounds
After testing pure test compounds, the supernatants originatedfrom the steroidogenesis assay have been examined.
Supernatant samples of H295R cells treated with positive con-
trols (forskolin and prochloraz) or atrazine did not show cytotoxic
effect in BLYR test.
The effects of positive control inducer forskolin and inhibitor
prochloraz, elevating and reducing estradiol and testosterone
production in cells at the same time, have been measured in BLYES/
BLYAS assays. In both cases, the relative responses of estrogen and
androgen hormones produced by H295R cells after exposing them
to forskolin and prochloraz have met expectations. BLYES and
BLYAS assays produced increased bioluminescence after exposing
them to supernatants of forskolin treated H295R cells, while bio-
reporters showed decreased values after exposing them to super-
natants of prochloraz treated H295R cells. These results indicate
that BLYES and BLYAS are able to detect inductive and inhibitory
effects of forskolin and prochloraz in a concentration-dependent
manner (Fig. 2).
Lowest observed effect concentrations, 0.3 and 0.1 mM of for-
skolin and 0.3 and 0.03 mMof prochloraz, signiﬁcantly elevated and
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H295R cells, respectively. At a concentration 10 mM of forskolin,
increases in levels of estrogen and androgen hormones resulted in
38% bioluminescence intensiﬁcation of BLYES and 67% biolumi-
nescence intensiﬁcation of BLYAS strains compared to the solvent
(DMSO) control (SC). 3 mM of prochloraz completely blocked the
basal aromatase activity (i.e. estrogen production), thus BLYES
detected 92% decrease in bioluminescence compared to SC, while
decreased androgenicity resulted in 76% less bioluminescence
(Fig. 2). The EC50 values measured by the BLYES and BLYAS tests
were 0.609 mM and 0.83 mM for forskolin and 0.14 mM and
0.0358 mM for prochloraz, respectively (Table 2). These values fall
within the expected hormone effective ranges of the positive
control chemicals recommended by the OPSCC Guideline. These
data, meeting the Guideline's requirements regarding the sensi-
tivity of the hormonemeasurement system, help the validation and
are conﬁrming the efﬁciency of yeast based bioreporter tests in the
combined method.
Atrazine induced both estrogen and androgen production in
H295R cells concentration-dependently after 48 h exposure and
the elevated estrogenic and androgenic effects were detected by
strains of S. cerevisiae BLYAS and BLYES after 5-h contact time.
Lowest observed effect concentrations of atrazine were 1 and 3 mM
resulting in signiﬁcant increase in estrogenic and androgenic ef-
fects in the supernatants measured by BLYES and BLYAS, respec-
tively (Fig. 3).Fig. 2. Estrogenic and androgenic effects in supernatants of H295R cells measured by BLYE
inducer forskolin (A) and inhibitor prochloraz (B). Data are expressed as percentage of the
maximum inhibition ¼ 100%). Bioluminescence intensiﬁcation data (C, D) have been calcul
(0%). One-way ANOVA followed by the Tukey's post hoc test was used. Data are presented as
(p < 0.05), (þþ) signiﬁcantly different from control (p < 0.01), (***, þþþ) signiﬁcantly diffOver 10 mM of atrazine H295R cells produced elevated estrogen
level that caused more than 20% bioluminescence intensiﬁcation in
the BLYES test, at concentrations of 100 and 300 mM atrazine the
intensiﬁcations were 40 and 52%, respectively. BLYAS test showed
30, 100 and 300 mM atrazine was able to increase androgen pro-
duction in H295R cells. This caused 23, 31 and 48% bioluminescence
intensiﬁcation in the yeast cells compared to the solvent control
(Fig. 3).
Elevated hormone activity of estrogens and androgens produced
by H295R cells resulted in 50% increase in maximal biolumines-
cence (EC50) after exposure to 16.78 mM (BLYES) and 34.38 mM
(BLYAS) atrazine, respectively (Fig. 3).4. Discussion
In this study, a combined assay has been developed to analyze
endocrine disrupting effect resulting from compounds with non-
direct receptor binding. For that reason, S. cerevisiae BLYES and
BLYASwere adapted to H295R cell lines. The aromatase inducer and
adenylyl-cyclase activator forskolin has to elevate both estrogen
and androgen level according to the OCSPP guideline for ste-
roidogenesis (USEPA, 2011), showed increased estrogenic and
androgenic effects when supernatant of the H295R cells have been
tested. Moreover, the aromatase inhibitor prochloraz is also known
as an antiandrogenic chemical (Vinggaard et al., 2002), resulted in
decreased level of estrogens and androgens having been detectedS and BLYAS strains after 5 h contact time. Cells were exposed for 48 h to the known
maximum and minimum bioluminescence values (CPS) (maximum induction ¼ 100%;
ated as described in the Methods from CPS values compared to the solvent control (SC)
mean ± SD of three independent experiments. (*, þ) Signiﬁcantly different from control
erent from control (p < 0.001).
Fig. 3. Concentration-response curves show concentration-dependent elevation of estrogenic (A) and androgenic (B) effect in the supernatants of H295R adrenocortical carcinoma
cells after 48 h exposure to atrazine. Data are expressed in percentage of the maximum bioluminescence (CPS) measured by BLYES and BLYAS at 5 h contact time. Each con-
centration of atrazine from 1 to 3 mM resulted in signiﬁcantly elevated estrogenic and androgenic activity in the supernatants of human cells, respectively and was measured by
BLYES and BLYAS compared to the solvent control (SC). Bioluminescence intensiﬁcation data (C) in the bioreporter assays caused by increased estrogenic and androgenic effects
were calculated as described in the Methods comparing the bioluminescence values of the supernatants to the solvent control (SC) (0%). One-way ANOVA followed by the Tukey's
post hoc test was used. Data are presented as mean ± SD from three independent experiments. (**, þþ) Signiﬁcantly different from control (p < 0.01), (***, þþþ) signiﬁcantly
different from control (p < 0.001).
J. Hahn et al. / Chemosphere 154 (2016) 507e514512by the BLYES and BLYAS bioreporters.
The aromatase-inductive effect of atrazine has been widely
examined in several in vivo and in vitro studies. According to pre-
vious results, atrazine caused increased estrogen level in plasma,
demasculinization in frogs and increased incidence of estrogen-
dependent tumours that indicated the investigation of inductive
effects of atrazine on aromatase. In previous in vivo studies,
decreased testosterone level was observed in plasma in parallel
with increased estrogen production (Friedmann, 2002; Trentacoste
et al., 2001; Hayes et al., 2006). However, the regulation ofTable 2
Comparison of the expected EC50 ranges and themeasured EC50 values regarding the
positive control forskolin and prochloraz.
Inducer/Inhibitor EC50 (mM) values
E2a Ta BLYESb BLYASb
Forskolin 0.3e3.0 0.2e2.0 0.609 0.830
Prochloraz 0.03e0.03 0.01e0.1 0.140 0.0358
a Expected EC50 ranges for forskolin and prochloraz using 17b-estradiol (E2) and
testosterone (T) as measuring end-points (OCSPP Guideline 890.1550).
b EC50 values for forksolin and prochloraz using yeast based bioreporter tests to
measure hormone activity in supernatants of H295R cells (BLYES for estrogenicity
and BLYAS for androgenicity) in this study.steroidogenic genes is very difﬁcult and the effects of various EDCs
are highly complex and poorly understood.
Aside from the expected estrogenic effect, our study has shown
that atrazine is able to induce the synthesis of androgen hormones
in H295R human adrenocortical cells, as well.
The main subset of androgens, known as adrenal androgens, is
composed of 19-carbon steroids synthesized in the zona reticularis,
the innermost layer of the adrenal cortex. Beside testosterone, be-
ing the main target of androgens in steroidogenesis assays, an-
drogens include other hormones i.e. dehydroepiandrosterone,
androstendione, androstendiol, androsterone and dihy-
drotestosterone. Atrazine showed inhibitory effect of 5a-reductase
in earlier studies. This enzyme is most known to convert testos-
terone into the more potent androgen, dihydrotestosterone (Babic-
Gojmerac et al., 1989; Kniewald et al., 1979). However, increased
androgenic effect detected in BLYAS test can be attributed to
neither aromatase inductor nor to 5a-reductase inhibitory effect.
Atrazine may induce other enzyme activity and/or gene expression
involved in the synthesis of androgenic hormones in H295R cells
causing androgenicity. The in vivo and in vitro aromatase inducer
effect of atrazine is well documented in the literature, but the
increased androgen production induced by the chemical, up to the
best of the authors' knowledge, has been only recorded in a couple
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androgen production induced by short-term atrazine treatment in
rat Leydig-cells in vitro and in vivo and it was found that atrazine
has a transient stimulatory action on steroidogenesis. When
studying H295R cells, Higley et al. (2010) demonstrated that in
response to atrazine the cells produce more estradiol and testos-
terone. The result of the combined method we have developed
seems to support this; in response to atrazine the androgen and
estrogen synthesis in H295R human adrenocortical carcinoma cells
increased, and this resulted in an increased androgenic and estro-
genic effect in the bioreporter test.
The H295R cell line combined with BLYES/BLYAS bioreporter
system applied in the present study has been proven useful in
identifying the cumulated biological effect of atrazine in sex steroid
synthesis in vitro.
One of the advantages of the semi-quantitative method, it does
not require measurement of pre-speciﬁed analytical endpoints
demanding various kits and methods, since the BLYES/BLYAS sys-
tem is suitable for the detection of molecules being able to attach
directly to the human estrogen and androgen receptors without
individual measurement of the different components.
Furthermore, the combined test allows for rapid and simple
detection of the complex, indirect effect of chemicals, even com-
bination of chemicals, certain metabolites on sex steroid synthesis
without the need for costly chemical and/or immunoanalytical
evaluations and related preparation and extraction procedures.
Additionally, the method is also applicable in cases when the effect
of the test substance(s) on steroid synthesis, hence the analytical
endpoints are not possible to pre-specify accurately. By using the
complex effect evaluation the false negative results due to inade-
quate selection and use of measurement endpoints can be avoided
and the method can be a useful tool to determine the most suitable
further tests and assays more efﬁciently.
These properties of the combined method meet many of the
recommendation proposed by EDSTAC (1998) considering the
scope of the Tier 1 screening and testing strategy, such as that the
assays should: i. be inexpensive, quick, easy to perform; ii. capture
multiple endpoints. Moreover, it fulﬁls the need that the test should
be predictive across species; hence most of the genes and enzymes
involved in adrenal steroidogenesis are present and serve the
identical biochemical role in several different species and classes.
After further validation and standardization, the developed com-
bined assay can be a supplementary method assessing the indirect
endocrine disrupting ability of chemicals and mixtures.
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